A drop in blood pressure particularly upon standing (orthostatic hypotension) can cause transient dizziness, especially in the early weeks of treatment or following dose escalation
On top of this, risks may include: No FDA-Approval for Safety or Effectiveness Unlike prescription GLP-1 drugs, which undergo rigorous testing, these patches are sold as supplements and are not reviewed by the FDA for effectiveness before being marketed, and quality may vary by the product
PlexusDx pairs microdose options with personalized guidance, removing the guesswork from dose selection and ensuring you only pay for what you need
Ce tripeptide, compos de glutamate, cystine et glycine, est synthtis par le foie et prsent dans chaque cellule de l'organisme
Other Ingredients: Cellulose (capsule), Microcrystalline cellulose, vegetable stearate, silicon dioxide
All guidance is individualized, clinically cautious, and grounded in current scientific limitations